MENU
PRLD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Prelude Therapeutics (PRLD) Ownership - Who owns Prelude Therapeutics?
Profile
Industry
N/A
Address
175 Innovation Boulevard
Phone
+1 302 467-1280
Employees
128
Web
https://www.preludetx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
48.82M
P/E Ratio
N/A
Total Cash
153.63M
Projected Growth
N/A
Total Debt
18.14M
Revenue
3M
Risk (Beta)
1.55
Dividend Yield
N/A
Total Cash/Share
2.79
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
Fundamentals
PRLD
Capitalization
48.8M
P/E Ratio
N/A
Risk (Beta)
1.55
Dividend Yield
N/A
Total Cash
154M
Total Cash/Share
2.79
Total Debt
18.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
3M
ROE
N/A
Book Value
156M
P/B Ratio
0.31
Cash Flow
N/A
Earnings
-1.77
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
7.04
Current Revenue Per Employee
23437.50
Dividends Per Share - Security
N/A
EBITDA
-141.65M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-57.72
Shares Held By Institutions
111M
Shares Outstanding - Current
55M
Total Liabilities
40.8M
Total Volume MTD
N/A
Value
1
Gain YTD
-79.227
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
175 Innovation Boulevard
Phone
+1 302 467-1280
Employees
128
Web
https://www.preludetx.com